<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:8daf37a7-77d2-4a83-a6f6-0ee611ac6f75,g:5d70d678-b56c-412c-8cc7-e216a062a491-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://arbutusbio.com/role/Cover" xlink:type="simple" xlink:href="abus-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_605bb0e8-db41-4558-ba88-9f8e19dd3db2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_DocumentType_605bb0e8-db41-4558-ba88-9f8e19dd3db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_982933dc-e380-4a8e-8aca-1d7de5d9dd77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_DocumentQuarterlyReport_982933dc-e380-4a8e-8aca-1d7de5d9dd77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7dba538b-0ba0-4266-aa9b-4ce8fc13616e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_DocumentPeriodEndDate_7dba538b-0ba0-4266-aa9b-4ce8fc13616e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_906b2ff1-f1c5-4520-99d8-81a30527e241" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_DocumentTransitionReport_906b2ff1-f1c5-4520-99d8-81a30527e241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_27d8f7cc-0565-488c-93b8-c6dc535c1008" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityFileNumber_27d8f7cc-0565-488c-93b8-c6dc535c1008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6e6fab07-dded-4ce5-99fa-797ca34fd6a6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityRegistrantName_6e6fab07-dded-4ce5-99fa-797ca34fd6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7ddbb86f-970c-46fe-a995-bda6708ebe48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7ddbb86f-970c-46fe-a995-bda6708ebe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a44a35a8-5c18-4083-88ee-bb9bca7d4006" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityTaxIdentificationNumber_a44a35a8-5c18-4083-88ee-bb9bca7d4006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_027e16ce-d3fc-4eae-b393-ac192b6f525a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityAddressAddressLine1_027e16ce-d3fc-4eae-b393-ac192b6f525a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ebc0b522-0cf9-4937-9dcf-69c57355cb11" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityAddressCityOrTown_ebc0b522-0cf9-4937-9dcf-69c57355cb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1cd65a01-766c-4653-ad11-1e64db988416" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityAddressStateOrProvince_1cd65a01-766c-4653-ad11-1e64db988416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_91a0672e-7ebd-4caa-a4e8-0519ff8d333e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityAddressPostalZipCode_91a0672e-7ebd-4caa-a4e8-0519ff8d333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7671cef0-5fc6-4768-a9db-9af5caec2017" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_CityAreaCode_7671cef0-5fc6-4768-a9db-9af5caec2017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a468896d-78a0-4123-a24e-607142987d84" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_LocalPhoneNumber_a468896d-78a0-4123-a24e-607142987d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a49c23c6-888f-4564-a7d1-2585eaa9d3c2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_Security12bTitle_a49c23c6-888f-4564-a7d1-2585eaa9d3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_ba284735-13c5-4a49-8a6f-d40601529b06" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_TradingSymbol_ba284735-13c5-4a49-8a6f-d40601529b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_91c9180f-4f60-4147-a455-6355952ac884" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_SecurityExchangeName_91c9180f-4f60-4147-a455-6355952ac884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f7e32d51-c1ae-47a3-83db-84ea712d154a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityCurrentReportingStatus_f7e32d51-c1ae-47a3-83db-84ea712d154a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_2ef03fa0-9d95-4ab0-b53f-68e026c1e95d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityInteractiveDataCurrent_2ef03fa0-9d95-4ab0-b53f-68e026c1e95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_39ea8a96-859d-4abd-8458-66ab797c9514" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityFilerCategory_39ea8a96-859d-4abd-8458-66ab797c9514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_750a5d91-e808-40fa-82f4-b4b3b274be08" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntitySmallBusiness_750a5d91-e808-40fa-82f4-b4b3b274be08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_824580ff-5080-4c5d-b012-9283e23ed828" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityEmergingGrowthCompany_824580ff-5080-4c5d-b012-9283e23ed828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_c8926173-421a-40e4-b314-def4418b52c9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityShellCompany_c8926173-421a-40e4-b314-def4418b52c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_72901745-d1ab-4098-adb7-67a991157275" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_72901745-d1ab-4098-adb7-67a991157275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6fd972dd-df5d-4be2-aa67-8cd962962ce3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_AmendmentFlag_6fd972dd-df5d-4be2-aa67-8cd962962ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a490e78b-b088-46cc-94d8-839d9e725ac6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_EntityCentralIndexKey_a490e78b-b088-46cc-94d8-839d9e725ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_38bda239-9377-43a1-abe9-bf4c379b219e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_CurrentFiscalYearEndDate_38bda239-9377-43a1-abe9-bf4c379b219e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ae8dbc3d-44b0-4094-815f-fb2855580880" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_DocumentFiscalYearFocus_ae8dbc3d-44b0-4094-815f-fb2855580880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cfefe232-0e9f-49cb-b87d-172d1fcf3a0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b643686f-3e7a-4a95-bfa0-ecb87f878c71" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cfefe232-0e9f-49cb-b87d-172d1fcf3a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="abus-20220930.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_93818832-5b46-4fdd-8f23-4f1237f7d17c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_93818832-5b46-4fdd-8f23-4f1237f7d17c" xlink:to="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:to="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_183c423a-b42a-4089-bf64-29420e321798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_183c423a-b42a-4089-bf64-29420e321798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_66752f08-5361-4590-af7d-b1e878dff9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_66752f08-5361-4590-af7d-b1e878dff9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_82f6d29f-4b50-41d1-90ec-80f69e9e5f72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_82f6d29f-4b50-41d1-90ec-80f69e9e5f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e0c40103-699e-4361-b5e5-19731f852ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e0c40103-699e-4361-b5e5-19731f852ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2cab645a-645a-47de-a28e-93457cabd066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_af3d3796-8de9-43ce-beb2-4cff946d2000" xlink:to="loc_us-gaap_AssetsCurrent_2cab645a-645a-47de-a28e-93457cabd066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8696b22c-7241-41cd-8d91-7138a6cf3264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8696b22c-7241-41cd-8d91-7138a6cf3264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_d8723d54-f950-4d25-808b-01c6434abcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:to="loc_us-gaap_LongTermInvestments_d8723d54-f950-4d25-808b-01c6434abcdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_237d20fb-6abe-4f7a-aee9-4620b34b6ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_237d20fb-6abe-4f7a-aee9-4620b34b6ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1a4b45d0-29de-4294-86b4-d16041006f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1a4b45d0-29de-4294-86b4-d16041006f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1b4f26a1-69a0-4f31-bbbb-5ebce134efe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_bee8ba99-ad39-460c-a8d3-42681fddc414" xlink:to="loc_us-gaap_Assets_1b4f26a1-69a0-4f31-bbbb-5ebce134efe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_93818832-5b46-4fdd-8f23-4f1237f7d17c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ba1ad34b-4084-4731-b888-7d7deee532ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ba1ad34b-4084-4731-b888-7d7deee532ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b9a21d56-5aaa-4716-bb7d-1fbf3a47145a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ba1ad34b-4084-4731-b888-7d7deee532ef" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_b9a21d56-5aaa-4716-bb7d-1fbf3a47145a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_9a0acad0-d615-4880-94b0-639e9be8278a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ba1ad34b-4084-4731-b888-7d7deee532ef" xlink:to="loc_us-gaap_DeferredRevenueCurrent_9a0acad0-d615-4880-94b0-639e9be8278a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8ef752bb-c829-46be-a285-420e5013dc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ba1ad34b-4084-4731-b888-7d7deee532ef" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8ef752bb-c829-46be-a285-420e5013dc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_095efbd6-8ec8-40b6-a3a3-434f4354c307" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ba1ad34b-4084-4731-b888-7d7deee532ef" xlink:to="loc_us-gaap_LiabilitiesCurrent_095efbd6-8ec8-40b6-a3a3-434f4354c307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_d5415cb2-7405-4547-a29e-6fb9bbd6c88d" xlink:href="abus-20220930.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_d5415cb2-7405-4547-a29e-6fb9bbd6c88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f256941e-957d-40ad-afaf-b3f020ec1c18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_f256941e-957d-40ad-afaf-b3f020ec1c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_e2384d12-dada-430d-8b98-a1e60978bad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_e2384d12-dada-430d-8b98-a1e60978bad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_def72573-ffbd-4159-8862-c06323090111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_def72573-ffbd-4159-8862-c06323090111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5e25f6a8-0c77-45d4-a865-c2211261bebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_Liabilities_5e25f6a8-0c77-45d4-a865-c2211261bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_459ce594-a92f-4cea-97bd-fda8e9c986aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:to="loc_us-gaap_CommonStockValue_459ce594-a92f-4cea-97bd-fda8e9c986aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_faf5a029-1986-4940-a8f3-689efa359030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_faf5a029-1986-4940-a8f3-689efa359030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c7ed0a50-6a47-43ab-a9a7-38aa36ce0c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c7ed0a50-6a47-43ab-a9a7-38aa36ce0c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d1eca2ba-d47e-46be-a7c9-ab5efbc887ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d1eca2ba-d47e-46be-a7c9-ab5efbc887ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_691f68b3-f79a-4c4c-a061-93d85fd48b18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c79acea6-1bee-4ab7-b15d-1f26d24b021f" xlink:to="loc_us-gaap_StockholdersEquity_691f68b3-f79a-4c4c-a061-93d85fd48b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0f6e773e-dfe7-4627-af19-0693dc22ece4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0f150eaa-9e29-450f-99fd-7a96c5a48c65" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0f6e773e-dfe7-4627-af19-0693dc22ece4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="abus-20220930.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ecb775fc-c893-4240-8ada-30246b2899f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eeb4b4a0-55fe-4ec9-8c5c-3b0d11af48e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ecb775fc-c893-4240-8ada-30246b2899f8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eeb4b4a0-55fe-4ec9-8c5c-3b0d11af48e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_43364ba9-e7d6-4ed5-b88c-9314219b9c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ecb775fc-c893-4240-8ada-30246b2899f8" xlink:to="loc_us-gaap_CommonStockSharesIssued_43364ba9-e7d6-4ed5-b88c-9314219b9c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a899f178-5594-4722-8229-75ae01472fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ecb775fc-c893-4240-8ada-30246b2899f8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a899f178-5594-4722-8229-75ae01472fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="simple" xlink:href="abus-20220930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4ec197f2-00d8-4a1e-a544-ca79644b40f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f0dbadf6-356a-4c73-9354-435a5f2f11e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4ec197f2-00d8-4a1e-a544-ca79644b40f4" xlink:to="loc_us-gaap_StatementTable_f0dbadf6-356a-4c73-9354-435a5f2f11e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4c3344e0-530f-4635-9256-05ded5f3786b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f0dbadf6-356a-4c73-9354-435a5f2f11e4" xlink:to="loc_srt_ProductOrServiceAxis_4c3344e0-530f-4635-9256-05ded5f3786b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92ae6f94-b539-4c4b-ae67-27c3b501c285" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4c3344e0-530f-4635-9256-05ded5f3786b" xlink:to="loc_srt_ProductsAndServicesDomain_92ae6f94-b539-4c4b-ae67-27c3b501c285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CollaborationAndContractsMember_884a3cca-f054-44b3-b94d-1c978c31aa24" xlink:href="abus-20220930.xsd#abus_CollaborationAndContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92ae6f94-b539-4c4b-ae67-27c3b501c285" xlink:to="loc_abus_CollaborationAndContractsMember_884a3cca-f054-44b3-b94d-1c978c31aa24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_f80214db-4d6d-4b13-a730-e1fe7f88dbf1" xlink:href="abus-20220930.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92ae6f94-b539-4c4b-ae67-27c3b501c285" xlink:to="loc_abus_NonCashRoyaltyMember_f80214db-4d6d-4b13-a730-e1fe7f88dbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0c02cd6c-0018-4c13-8769-95d258fed11d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f0dbadf6-356a-4c73-9354-435a5f2f11e4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0c02cd6c-0018-4c13-8769-95d258fed11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_822de9cf-2286-40cf-8f51-14310349287b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0c02cd6c-0018-4c13-8769-95d258fed11d" xlink:to="loc_us-gaap_EquityComponentDomain_822de9cf-2286-40cf-8f51-14310349287b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f0dbadf6-356a-4c73-9354-435a5f2f11e4" xlink:to="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_0ccb643a-575a-407b-8cc8-932e938eb15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_RevenuesAbstract_0ccb643a-575a-407b-8cc8-932e938eb15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b511a95d-7a9f-435d-a18e-77d191303534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_0ccb643a-575a-407b-8cc8-932e938eb15b" xlink:to="loc_us-gaap_Revenues_b511a95d-7a9f-435d-a18e-77d191303534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_869e6fa4-02d8-4212-99c6-67885ca85238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_OperatingExpensesAbstract_869e6fa4-02d8-4212-99c6-67885ca85238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2e78d04a-9e90-43aa-989a-c7290c0c8d91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_869e6fa4-02d8-4212-99c6-67885ca85238" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2e78d04a-9e90-43aa-989a-c7290c0c8d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_24fbe70b-5e35-4179-8726-80058b11e1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_869e6fa4-02d8-4212-99c6-67885ca85238" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_24fbe70b-5e35-4179-8726-80058b11e1c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_a04dee0a-8040-4856-838f-58385900d06b" xlink:href="abus-20220930.xsd#abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_869e6fa4-02d8-4212-99c6-67885ca85238" xlink:to="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_a04dee0a-8040-4856-838f-58385900d06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_37c5d30a-12a3-43b9-b545-81e4faa11710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_869e6fa4-02d8-4212-99c6-67885ca85238" xlink:to="loc_us-gaap_OperatingExpenses_37c5d30a-12a3-43b9-b545-81e4faa11710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c63538b6-2b9b-4276-9ccb-1751e289275d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_OperatingIncomeLoss_c63538b6-2b9b-4276-9ccb-1751e289275d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_46c1e813-30fa-41b0-9101-74249ac1eeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_InvestmentIncomeInterest_46c1e813-30fa-41b0-9101-74249ac1eeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c81ecfbd-5763-49aa-a4af-5c12580620f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_InterestExpense_c81ecfbd-5763-49aa-a4af-5c12580620f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_13aaaeaf-3964-4f87-8e3d-275242a47fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_13aaaeaf-3964-4f87-8e3d-275242a47fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d87b54b9-23f7-4ed9-8805-3526b34c8ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d87b54b9-23f7-4ed9-8805-3526b34c8ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c1eb97f8-680c-4a85-b4c2-6ee37be250ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c1eb97f8-680c-4a85-b4c2-6ee37be250ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cd187eeb-ec58-4530-a5b6-55ecfde4cc1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_NetIncomeLoss_cd187eeb-ec58-4530-a5b6-55ecfde4cc1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_62f66c83-2433-472e-a5c9-cd6c5c99bd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_62f66c83-2433-472e-a5c9-cd6c5c99bd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_4c3ed10b-cb6d-49e7-bc45-e321b813cbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_62f66c83-2433-472e-a5c9-cd6c5c99bd8d" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_4c3ed10b-cb6d-49e7-bc45-e321b813cbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_94882ac0-f902-45c4-86b0-b3612fdf7d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_94882ac0-f902-45c4-86b0-b3612fdf7d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fedcbee7-93d8-4a66-8d79-d3cacc95d847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_EarningsPerShareAbstract_fedcbee7-93d8-4a66-8d79-d3cacc95d847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ca53ee29-5611-48fc-a70c-b963ea675526" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fedcbee7-93d8-4a66-8d79-d3cacc95d847" xlink:to="loc_us-gaap_EarningsPerShareBasic_ca53ee29-5611-48fc-a70c-b963ea675526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d1569735-cb06-47b9-9d49-e585e33f4eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fedcbee7-93d8-4a66-8d79-d3cacc95d847" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d1569735-cb06-47b9-9d49-e585e33f4eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_934ca733-0c2f-4100-92f4-8d0aa455afd2" xlink:href="abus-20220930.xsd#abus_WeightedAverageNumberOfCommonSharesAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_934ca733-0c2f-4100-92f4-8d0aa455afd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74f67993-d3a4-40fa-9ef7-53666c3acf57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_934ca733-0c2f-4100-92f4-8d0aa455afd2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74f67993-d3a4-40fa-9ef7-53666c3acf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d906e84d-f647-41dc-86b4-2f39ac6dd976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_934ca733-0c2f-4100-92f4-8d0aa455afd2" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d906e84d-f647-41dc-86b4-2f39ac6dd976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d0e11425-4708-481b-879e-9b9aa1df5a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d0e11425-4708-481b-879e-9b9aa1df5a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4b5af048-72cd-423b-800b-41ce29f4e868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d0e11425-4708-481b-879e-9b9aa1df5a4a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_4b5af048-72cd-423b-800b-41ce29f4e868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3dbe58df-2bf7-49e5-92c6-43b48d3c316f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_d0e11425-4708-481b-879e-9b9aa1df5a4a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3dbe58df-2bf7-49e5-92c6-43b48d3c316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ba5f605d-cceb-48a5-8cfe-a2779e66b683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_30811c41-984e-442f-829f-cf75701ca6a8" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ba5f605d-cceb-48a5-8cfe-a2779e66b683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedStatementofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="abus-20220930.xsd#CondensedConsolidatedStatementofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedStatementofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_f52511f8-5034-4632-a69c-2dc9a91fbc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b0fe9bed-bf89-476d-88de-837e64bd29da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_f52511f8-5034-4632-a69c-2dc9a91fbc3c" xlink:to="loc_us-gaap_StatementTable_b0fe9bed-bf89-476d-88de-837e64bd29da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8c8698de-ff4a-4568-b467-b55ca7227a02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b0fe9bed-bf89-476d-88de-837e64bd29da" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8c8698de-ff4a-4568-b467-b55ca7227a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8c8698de-ff4a-4568-b467-b55ca7227a02" xlink:to="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a1c17673-74b7-4006-95df-21eb6313a056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:to="loc_us-gaap_CommonStockMember_a1c17673-74b7-4006-95df-21eb6313a056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fd1b7659-1c82-47e0-8ba3-dfb2c757cb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fd1b7659-1c82-47e0-8ba3-dfb2c757cb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5fbb6fec-9864-4e9c-8912-dddb8f1017d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:to="loc_us-gaap_RetainedEarningsMember_5fbb6fec-9864-4e9c-8912-dddb8f1017d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c7c5c805-0200-4330-9da3-045746f9854b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c7c5c805-0200-4330-9da3-045746f9854b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_cf20140c-4e7a-47c9-a61b-da2c4f04f70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c49a8e9a-386e-4f63-894c-6e701ba894dd" xlink:to="loc_us-gaap_PreferredStockMember_cf20140c-4e7a-47c9-a61b-da2c4f04f70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_4ef425b2-ce9d-441b-966c-1755b6980010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b0fe9bed-bf89-476d-88de-837e64bd29da" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_4ef425b2-ce9d-441b-966c-1755b6980010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa5929fd-a0b0-4644-aa7f-3b93065d7e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_4ef425b2-ce9d-441b-966c-1755b6980010" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa5929fd-a0b0-4644-aa7f-3b93065d7e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OpenMarketSaleAgreementMember_0626cd02-2108-40cf-9e80-43f22d0879ea" xlink:href="abus-20220930.xsd#abus_OpenMarketSaleAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa5929fd-a0b0-4644-aa7f-3b93065d7e99" xlink:to="loc_abus_OpenMarketSaleAgreementMember_0626cd02-2108-40cf-9e80-43f22d0879ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharePurchaseAgreementMember_d1e96aa9-bd6d-4537-bab5-f4574b23f9bc" xlink:href="abus-20220930.xsd#abus_SharePurchaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fa5929fd-a0b0-4644-aa7f-3b93065d7e99" xlink:to="loc_abus_SharePurchaseAgreementMember_d1e96aa9-bd6d-4537-bab5-f4574b23f9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_118a5e24-d222-4561-b2ae-47194e471dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b0fe9bed-bf89-476d-88de-837e64bd29da" xlink:to="loc_us-gaap_StatementLineItems_118a5e24-d222-4561-b2ae-47194e471dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_118a5e24-d222-4561-b2ae-47194e471dc8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_a30a23dc-3eb0-4a41-874a-09289fc56dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_SharesIssued_a30a23dc-3eb0-4a41-874a-09289fc56dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_94b495b9-9e0d-416d-ab34-20ac675fb59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockholdersEquity_94b495b9-9e0d-416d-ab34-20ac675fb59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockAccretionOfRedemptionDiscount_8cbc2b99-a090-4b96-a85a-5d116879ecef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_PreferredStockAccretionOfRedemptionDiscount_8cbc2b99-a090-4b96-a85a-5d116879ecef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d05d8332-536e-48f7-8d97-f462d6c36346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d05d8332-536e-48f7-8d97-f462d6c36346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_b3182753-0280-4231-8bb4-01d1f0252c3a" xlink:href="abus-20220930.xsd#abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_b3182753-0280-4231-8bb4-01d1f0252c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_259746c4-cb46-4309-b8eb-991a5d52d4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_259746c4-cb46-4309-b8eb-991a5d52d4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_43bc348f-c539-4aa2-be04-f3dbfa09dfbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_43bc348f-c539-4aa2-be04-f3dbfa09dfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6ad4f0bb-7366-42a9-b058-30c2528ba18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6ad4f0bb-7366-42a9-b058-30c2528ba18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5c4384c1-7a5e-40c4-be0a-e7827b67a360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5c4384c1-7a5e-40c4-be0a-e7827b67a360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7a019ca1-181a-484f-bc66-1a948059c47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_7a019ca1-181a-484f-bc66-1a948059c47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_87a3cea5-6b2c-40ac-bdab-733cf2639591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_87a3cea5-6b2c-40ac-bdab-733cf2639591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_90ffa1a2-7761-4d1f-b941-d08a418fc5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_90ffa1a2-7761-4d1f-b941-d08a418fc5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a852ce26-f85d-485b-bcb4-7fa5107a542d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_NetIncomeLoss_a852ce26-f85d-485b-bcb4-7fa5107a542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ea11e1d1-6daa-4174-9b0e-d1868c9db48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_SharesIssued_ea11e1d1-6daa-4174-9b0e-d1868c9db48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_10cab161-b782-4880-8939-4394f51cc0db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2331ddd4-c871-4ede-b893-4f7e54b09f46" xlink:to="loc_us-gaap_StockholdersEquity_10cab161-b782-4880-8939-4394f51cc0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedStatementsofCashFlowUnaudited" xlink:type="simple" xlink:href="abus-20220930.xsd#CondensedConsolidatedStatementsofCashFlowUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedStatementsofCashFlowUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9532e2aa-ad39-4a5b-a77f-9ee8235a4cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3b736240-2c03-45bf-b4e3-eade6584c41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9532e2aa-ad39-4a5b-a77f-9ee8235a4cb5" xlink:to="loc_us-gaap_StatementTable_3b736240-2c03-45bf-b4e3-eade6584c41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_581a03d0-e1a7-4612-b383-e76955db1bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b736240-2c03-45bf-b4e3-eade6584c41a" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_581a03d0-e1a7-4612-b383-e76955db1bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a330151c-79aa-4c4e-b653-a61f3e2a7d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_581a03d0-e1a7-4612-b383-e76955db1bc6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a330151c-79aa-4c4e-b653-a61f3e2a7d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharePurchaseAgreementMember_f749849f-b6e3-4740-8a1d-f24b38c580ad" xlink:href="abus-20220930.xsd#abus_SharePurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a330151c-79aa-4c4e-b653-a61f3e2a7d68" xlink:to="loc_abus_SharePurchaseAgreementMember_f749849f-b6e3-4740-8a1d-f24b38c580ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OpenMarketSaleAgreementMember_5ceaa089-3873-49c0-89ad-4fdc68a57844" xlink:href="abus-20220930.xsd#abus_OpenMarketSaleAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a330151c-79aa-4c4e-b653-a61f3e2a7d68" xlink:to="loc_abus_OpenMarketSaleAgreementMember_5ceaa089-3873-49c0-89ad-4fdc68a57844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3b736240-2c03-45bf-b4e3-eade6584c41a" xlink:to="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_071f9838-edae-4c00-a1f0-f96040469f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_071f9838-edae-4c00-a1f0-f96040469f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e42f25e7-5588-452e-b0ca-2a033eef0097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_071f9838-edae-4c00-a1f0-f96040469f93" xlink:to="loc_us-gaap_NetIncomeLoss_e42f25e7-5588-452e-b0ca-2a033eef0097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_071f9838-edae-4c00-a1f0-f96040469f93" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_86058c1d-b5ca-4e37-a972-4a453f69f7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_86058c1d-b5ca-4e37-a972-4a453f69f7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_812a774e-680e-400a-9d76-819b91acaab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_812a774e-680e-400a-9d76-819b91acaab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9e94eae1-d602-4e8f-b3c4-f462a571ff38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_us-gaap_ShareBasedCompensation_9e94eae1-d602-4e8f-b3c4-f462a571ff38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a4de8b86-ed81-440d-ae81-b42553a0abff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a4de8b86-ed81-440d-ae81-b42553a0abff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_9deb9031-4c32-44fc-9f9b-81b533a2612e" xlink:href="abus-20220930.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_9deb9031-4c32-44fc-9f9b-81b533a2612e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties_5b5fc4f7-07ba-4b97-8483-3a74eff47106" xlink:href="abus-20220930.xsd#abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties_5b5fc4f7-07ba-4b97-8483-3a74eff47106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_8330d420-a0d4-479c-a42c-2c20f576b487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3324229d-9094-484e-b2c7-104d7374718b" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_8330d420-a0d4-479c-a42c-2c20f576b487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_071f9838-edae-4c00-a1f0-f96040469f93" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b53eceea-2f10-4762-8a1e-8bf34c0a9e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b53eceea-2f10-4762-8a1e-8bf34c0a9e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_89e29b7c-8144-4f72-a6ad-9547e60bd41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_89e29b7c-8144-4f72-a6ad-9547e60bd41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_dad0c22d-f296-4b84-9e54-4bb5cdf55ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_dad0c22d-f296-4b84-9e54-4bb5cdf55ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_fff9de71-9195-4242-bf81-c93719d5bba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_fff9de71-9195-4242-bf81-c93719d5bba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c90cf1e2-f5eb-40c6-9303-cb2bdc2149a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_7f586f18-7245-4856-b573-5f0253e71143" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c90cf1e2-f5eb-40c6-9303-cb2bdc2149a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4b4292ff-3846-4edf-b379-24ff721564cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_071f9838-edae-4c00-a1f0-f96040469f93" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4b4292ff-3846-4edf-b379-24ff721564cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_8841039a-3082-4048-809c-89c5215f5627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_8841039a-3082-4048-809c-89c5215f5627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_aa1a5e00-9e8a-4932-a5fa-3cf41bbddc61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_aa1a5e00-9e8a-4932-a5fa-3cf41bbddc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6d4618e2-e990-44a4-87e4-1839978b68d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_6d4618e2-e990-44a4-87e4-1839978b68d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ab03a96-961d-4773-bfb4-322b9b5732ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2ab03a96-961d-4773-bfb4-322b9b5732ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ed08273-4467-4d55-b875-0a26ce01e891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_14e23b7c-8f1a-405d-ae72-328f137a69fa" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6ed08273-4467-4d55-b875-0a26ce01e891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b76de3e4-3d9e-4c70-9ce6-73670dfd0be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b76de3e4-3d9e-4c70-9ce6-73670dfd0be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_c8f68d6f-e2ca-4980-ba16-2be2989cefc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b76de3e4-3d9e-4c70-9ce6-73670dfd0be6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_c8f68d6f-e2ca-4980-ba16-2be2989cefc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_398a2357-a074-4e8b-904c-bcae98b78810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b76de3e4-3d9e-4c70-9ce6-73670dfd0be6" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_398a2357-a074-4e8b-904c-bcae98b78810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_2bf3803b-241a-4ffa-9c1a-f41a687a5da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b76de3e4-3d9e-4c70-9ce6-73670dfd0be6" xlink:to="loc_us-gaap_ProceedsFromStockPlans_2bf3803b-241a-4ffa-9c1a-f41a687a5da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa516895-ca9a-479b-affd-0c5cdfb284dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b76de3e4-3d9e-4c70-9ce6-73670dfd0be6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa516895-ca9a-479b-affd-0c5cdfb284dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44cce6cf-5a62-4aa5-a794-5b0ef01c8969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44cce6cf-5a62-4aa5-a794-5b0ef01c8969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bfc94469-e5a7-48e0-a0bc-a28b0e187496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bfc94469-e5a7-48e0-a0bc-a28b0e187496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5139949b-0b4b-445c-bf72-d5b4bcc30b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5139949b-0b4b-445c-bf72-d5b4bcc30b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f312b890-5c0e-421c-867e-2e848ed91f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f312b890-5c0e-421c-867e-2e848ed91f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_310ecf12-08ec-4fbd-ab5c-0b270de0d3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f075ffc8-7181-47fd-9ea1-5d0d55264bc8" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_310ecf12-08ec-4fbd-ab5c-0b270de0d3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_44bac3b1-f0ce-428f-b855-f83d6071ae20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_310ecf12-08ec-4fbd-ab5c-0b270de0d3eb" xlink:to="loc_us-gaap_DividendsPreferredStockCash_44bac3b1-f0ce-428f-b855-f83d6071ae20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Natureofbusinessandfutureoperations" xlink:type="simple" xlink:href="abus-20220930.xsd#Natureofbusinessandfutureoperations"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Natureofbusinessandfutureoperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05ed6954-6605-4059-ae9d-2de13a12c806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_ab59af7f-5a4b-4f4d-a99c-4255bed9b12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05ed6954-6605-4059-ae9d-2de13a12c806" xlink:to="loc_us-gaap_NatureOfOperations_ab59af7f-5a4b-4f4d-a99c-4255bed9b12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Significantaccountingpolicies" xlink:type="simple" xlink:href="abus-20220930.xsd#Significantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Significantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6e29df0c-b942-4e52-8d18-2ee9b69f3b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_ef248e60-909f-47ff-bf06-6773d14db358" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6e29df0c-b942-4e52-8d18-2ee9b69f3b8a" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_ef248e60-909f-47ff-bf06-6773d14db358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="abus-20220930.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_20f5ccde-07fd-4a77-b7ba-69cf919889a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c7b604ae-af49-4d10-b41f-3bb32c6d1fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_20f5ccde-07fd-4a77-b7ba-69cf919889a1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c7b604ae-af49-4d10-b41f-3bb32c6d1fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Investmentsinmarketablesecurities" xlink:type="simple" xlink:href="abus-20220930.xsd#Investmentsinmarketablesecurities"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Investmentsinmarketablesecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f2f8296a-c795-4851-8c3a-4195e7744076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_3297421d-4228-4f6c-80c8-070f9709fd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_f2f8296a-c795-4851-8c3a-4195e7744076" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_3297421d-4228-4f6c-80c8-070f9709fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentinGenevant" xlink:type="simple" xlink:href="abus-20220930.xsd#InvestmentinGenevant"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentinGenevant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d8edba1a-3444-449a-a868-0e70f121cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_3670bae7-4831-4638-b1f0-f14227cde926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d8edba1a-3444-449a-a868-0e70f121cf88" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_3670bae7-4831-4638-b1f0-f14227cde926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Accountspayableandaccruedliabilities" xlink:type="simple" xlink:href="abus-20220930.xsd#Accountspayableandaccruedliabilities"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Accountspayableandaccruedliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e2518a93-91a6-4bb5-9998-0b979c1b6d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_39d93d97-be15-46ed-88d9-a98600c05888" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e2518a93-91a6-4bb5-9998-0b979c1b6d9f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_39d93d97-be15-46ed-88d9-a98600c05888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Saleoffutureroyalties" xlink:type="simple" xlink:href="abus-20220930.xsd#Saleoffutureroyalties"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Saleoffutureroyalties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_089f0a0b-2c3a-43f3-a6ba-26f1453e0a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock_bd86bb79-6e97-44ec-9378-ae0f7f722032" xlink:href="abus-20220930.xsd#abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_089f0a0b-2c3a-43f3-a6ba-26f1453e0a5f" xlink:to="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock_bd86bb79-6e97-44ec-9378-ae0f7f722032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Contingenciesandcommitments" xlink:type="simple" xlink:href="abus-20220930.xsd#Contingenciesandcommitments"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Contingenciesandcommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0d6c0212-dafa-4e42-852e-eba4f4a8d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Collaborationscontractsandlicensingagreements" xlink:type="simple" xlink:href="abus-20220930.xsd#Collaborationscontractsandlicensingagreements"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Collaborationscontractsandlicensingagreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_23325b56-1d74-452f-bbf8-1fbfe4b2efe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_4a266439-ebe3-436b-920f-1e5fbdf6458f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_23325b56-1d74-452f-bbf8-1fbfe4b2efe6" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_4a266439-ebe3-436b-920f-1e5fbdf6458f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Shareholdersequity" xlink:type="simple" xlink:href="abus-20220930.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_50cd064f-53b5-463f-b480-a78e510d169b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_34ba4fc8-0ff5-4944-8377-ab7e51ab2f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_50cd064f-53b5-463f-b480-a78e510d169b" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_34ba4fc8-0ff5-4944-8377-ab7e51ab2f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Relatedpartytransactions" xlink:type="simple" xlink:href="abus-20220930.xsd#Relatedpartytransactions"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Relatedpartytransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b7d436df-db82-486a-9476-5bad84e57b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_8c333dfc-b206-4bd3-b60b-12db59a94c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b7d436df-db82-486a-9476-5bad84e57b7a" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_8c333dfc-b206-4bd3-b60b-12db59a94c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="abus-20220930.xsd#SignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0d531377-4776-4dac-9424-92aefdd289bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0d531377-4776-4dac-9424-92aefdd289bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_360779a4-3483-40c4-9a8c-8ba6d8d2db1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_360779a4-3483-40c4-9a8c-8ba6d8d2db1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_222e29a6-846a-4e80-bf90-6c61b8fe4a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_222e29a6-846a-4e80-bf90-6c61b8fe4a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7a69ca76-1195-4c37-8d48-53ac914c6e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7a69ca76-1195-4c37-8d48-53ac914c6e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_301c7960-6373-417e-a4eb-58eb08fe6e43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_301c7960-6373-417e-a4eb-58eb08fe6e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a09cc0ed-9870-4c24-9212-e76932032c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a09cc0ed-9870-4c24-9212-e76932032c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_004643e4-7bfc-460f-98b0-53d95a92efb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5047696f-fb28-4339-aaf2-2bcc59f6b4b9" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_004643e4-7bfc-460f-98b0-53d95a92efb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="abus-20220930.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a305bce9-ca75-4df5-8eb3-a43c1f397676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_17867da3-c31f-4316-84dd-4459af728efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a305bce9-ca75-4df5-8eb3-a43c1f397676" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_17867da3-c31f-4316-84dd-4459af728efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="abus-20220930.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3eab3efe-06d7-4f4b-98c5-3b8f1d063426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_364299bf-d893-4728-afa7-c66ba38419c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3eab3efe-06d7-4f4b-98c5-3b8f1d063426" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_364299bf-d893-4728-afa7-c66ba38419c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_50b58cef-165f-4c75-8ce8-a601374c4497" xlink:href="abus-20220930.xsd#abus_ChangesInFairValueofLiabilityOptionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3eab3efe-06d7-4f4b-98c5-3b8f1d063426" xlink:to="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_50b58cef-165f-4c75-8ce8-a601374c4497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_eda8a713-da67-44bc-bb1f-0e472b2c4610" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3eab3efe-06d7-4f4b-98c5-3b8f1d063426" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_eda8a713-da67-44bc-bb1f-0e472b2c4610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesTables" xlink:type="simple" xlink:href="abus-20220930.xsd#InvestmentsinmarketablesecuritiesTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_85575422-538d-4d65-b139-6e22279f74e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_22c1715b-847e-46d7-a1e6-69cad01715fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_85575422-538d-4d65-b139-6e22279f74e8" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_22c1715b-847e-46d7-a1e6-69cad01715fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesTables" xlink:type="simple" xlink:href="abus-20220930.xsd#AccountspayableandaccruedliabilitiesTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6ff6a503-8a20-43e6-92a0-12ca3083553a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_8e05f56b-2fe4-401a-935a-da4e36cd08ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6ff6a503-8a20-43e6-92a0-12ca3083553a" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_8e05f56b-2fe4-401a-935a-da4e36cd08ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SaleoffutureroyaltiesTables" xlink:type="simple" xlink:href="abus-20220930.xsd#SaleoffutureroyaltiesTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SaleoffutureroyaltiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fcf58876-84bb-48c2-a246-3dbafbd6d34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock_bf6f5e42-c2b7-440a-83fe-455b8f9d9d81" xlink:href="abus-20220930.xsd#abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_fcf58876-84bb-48c2-a246-3dbafbd6d34e" xlink:to="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock_bf6f5e42-c2b7-440a-83fe-455b8f9d9d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsTables" xlink:type="simple" xlink:href="abus-20220930.xsd#CollaborationscontractsandlicensingagreementsTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e78fd17f-ea5c-4a9b-b987-864a02e47e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_19dbabc9-e57e-4bcf-a80a-57e4773bd48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e78fd17f-ea5c-4a9b-b987-864a02e47e05" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_19dbabc9-e57e-4bcf-a80a-57e4773bd48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_9bc2bcb4-0ead-4a91-a0a4-fca1d0ca74c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e78fd17f-ea5c-4a9b-b987-864a02e47e05" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_9bc2bcb4-0ead-4a91-a0a4-fca1d0ca74c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ShareholdersequityTables" xlink:type="simple" xlink:href="abus-20220930.xsd#ShareholdersequityTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ShareholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_b1821658-5d49-45fa-8dbf-fca4c901a93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f26869ab-211b-4e80-8972-85686b78a5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b1821658-5d49-45fa-8dbf-fca4c901a93a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_f26869ab-211b-4e80-8972-85686b78a5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/NatureofbusinessandfutureoperationsDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#NatureofbusinessandfutureoperationsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/NatureofbusinessandfutureoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d00002e6-f863-45c2-803d-0487f29d8b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e754fe46-7e77-40bb-875a-4c44143f8470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d00002e6-f863-45c2-803d-0487f29d8b93" xlink:to="loc_us-gaap_LongTermDebt_e754fe46-7e77-40bb-875a-4c44143f8470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndCash_48592a8e-f59a-4f91-bc40-80ff5f117c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAndCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d00002e6-f863-45c2-803d-0487f29d8b93" xlink:to="loc_us-gaap_InvestmentsAndCash_48592a8e-f59a-4f91-bc40-80ff5f117c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SignificantaccountingpoliciesDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#SignificantaccountingpoliciesDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SignificantaccountingpoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2cae52ad-2c03-4101-b7f6-a8707efb4142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_aeea4fbd-7224-4b40-af81-73f1d6832e82" xlink:href="abus-20220930.xsd#abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2cae52ad-2c03-4101-b7f6-a8707efb4142" xlink:to="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_aeea4fbd-7224-4b40-af81-73f1d6832e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_3cf376a6-ebe1-4e6f-b718-edc4c30e9802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2cae52ad-2c03-4101-b7f6-a8707efb4142" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_3cf376a6-ebe1-4e6f-b718-edc4c30e9802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_78130c7c-fab7-4a3f-abff-11563ad2676f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_3cf376a6-ebe1-4e6f-b718-edc4c30e9802" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_78130c7c-fab7-4a3f-abff-11563ad2676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bdfefa41-532e-440a-bd16-e410772a0b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_78130c7c-fab7-4a3f-abff-11563ad2676f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bdfefa41-532e-440a-bd16-e410772a0b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_55e90ba1-6704-4b25-81c2-1bccfa84046d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bdfefa41-532e-440a-bd16-e410772a0b5d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_55e90ba1-6704-4b25-81c2-1bccfa84046d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_3be5cd6a-8096-4293-ba4f-16208e4cca83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_3cf376a6-ebe1-4e6f-b718-edc4c30e9802" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_3be5cd6a-8096-4293-ba4f-16208e4cca83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_668b2c42-53d4-4106-8dc3-a890729d5a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3be5cd6a-8096-4293-ba4f-16208e4cca83" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_668b2c42-53d4-4106-8dc3-a890729d5a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_75f9a6bc-188f-42fd-9a49-8572e0ea142b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3be5cd6a-8096-4293-ba4f-16208e4cca83" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_75f9a6bc-188f-42fd-9a49-8572e0ea142b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_efaebf64-1308-478d-9203-3ff7723b460f" xlink:href="abus-20220930.xsd#abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3be5cd6a-8096-4293-ba4f-16208e4cca83" xlink:to="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_efaebf64-1308-478d-9203-3ff7723b460f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#FairvaluemeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_04397e61-e733-4f1c-9746-466e46605e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6c22c8ea-e2d0-4d73-a110-b3872012c771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04397e61-e733-4f1c-9746-466e46605e58" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6c22c8ea-e2d0-4d73-a110-b3872012c771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_81f40ca0-1644-41c3-9a7d-43543970e2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_04397e61-e733-4f1c-9746-466e46605e58" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_81f40ca0-1644-41c3-9a7d-43543970e2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#FairvaluemeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_74220641-d695-49bc-8d86-c842a80e252b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98f2795c-663f-42fd-99f2-ef8aa10658f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_74220641-d695-49bc-8d86-c842a80e252b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98f2795c-663f-42fd-99f2-ef8aa10658f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03f44629-c981-44d6-9042-78bcde0a4b97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98f2795c-663f-42fd-99f2-ef8aa10658f5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03f44629-c981-44d6-9042-78bcde0a4b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f27cb033-a750-4a47-a63a-02ec93081469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03f44629-c981-44d6-9042-78bcde0a4b97" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f27cb033-a750-4a47-a63a-02ec93081469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_ecc05e81-60b1-48c0-977c-59309ab529d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f27cb033-a750-4a47-a63a-02ec93081469" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_ecc05e81-60b1-48c0-977c-59309ab529d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e6751f07-689c-4bbf-8a89-3a18ab77339c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98f2795c-663f-42fd-99f2-ef8aa10658f5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e6751f07-689c-4bbf-8a89-3a18ab77339c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_872ceace-799b-49c5-86d6-16ac4f468561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e6751f07-689c-4bbf-8a89-3a18ab77339c" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_872ceace-799b-49c5-86d6-16ac4f468561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b1531c69-0ec4-4af5-8968-154c4ecf3e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_872ceace-799b-49c5-86d6-16ac4f468561" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b1531c69-0ec4-4af5-8968-154c4ecf3e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_45fcae72-d8e9-4d88-ad7c-9009817ed411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_872ceace-799b-49c5-86d6-16ac4f468561" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_45fcae72-d8e9-4d88-ad7c-9009817ed411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dbb077a7-c704-4062-8433-69204ec698c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_872ceace-799b-49c5-86d6-16ac4f468561" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dbb077a7-c704-4062-8433-69204ec698c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c7e99c8-2b56-462b-8c42-8497b881a3b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_98f2795c-663f-42fd-99f2-ef8aa10658f5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c7e99c8-2b56-462b-8c42-8497b881a3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_84966809-3db3-413d-83e3-7c1aa8d33cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c7e99c8-2b56-462b-8c42-8497b881a3b6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_84966809-3db3-413d-83e3-7c1aa8d33cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_68559522-c739-4d93-9ccc-5849f24eb4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_84966809-3db3-413d-83e3-7c1aa8d33cb0" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_68559522-c739-4d93-9ccc-5849f24eb4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_01c85885-f062-48dd-8799-fdcd89a714b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_84966809-3db3-413d-83e3-7c1aa8d33cb0" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_01c85885-f062-48dd-8799-fdcd89a714b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_7de0b5fb-8953-4eb1-a446-de4d4312dfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_84966809-3db3-413d-83e3-7c1aa8d33cb0" xlink:to="loc_us-gaap_LongTermInvestments_7de0b5fb-8953-4eb1-a446-de4d4312dfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0b10ff47-8aa9-4e48-827e-e95b273706c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_84966809-3db3-413d-83e3-7c1aa8d33cb0" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_0b10ff47-8aa9-4e48-827e-e95b273706c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_85290c41-ac11-4ed2-bbee-f5dc763ba79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2c7e99c8-2b56-462b-8c42-8497b881a3b6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_85290c41-ac11-4ed2-bbee-f5dc763ba79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_bb6d9e33-cb78-4fdc-a435-78c9175957ca" xlink:href="abus-20220930.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_85290c41-ac11-4ed2-bbee-f5dc763ba79e" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_bb6d9e33-cb78-4fdc-a435-78c9175957ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_85940f24-0ebd-4814-bfba-4947771905c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_85290c41-ac11-4ed2-bbee-f5dc763ba79e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_85940f24-0ebd-4814-bfba-4947771905c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_6e7ea32b-6498-4176-8951-0a116a8b7926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_85290c41-ac11-4ed2-bbee-f5dc763ba79e" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_6e7ea32b-6498-4176-8951-0a116a8b7926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofLiabilitiesClassifiedasStockOptionDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#FairvaluemeasurementsChangesinFairValueofLiabilitiesClassifiedasStockOptionDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofLiabilitiesClassifiedasStockOptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c8472a30-4123-4775-bd2e-f411e8bb56da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_727c593d-91d5-43fb-ad00-a788ebb29839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c8472a30-4123-4775-bd2e-f411e8bb56da" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_727c593d-91d5-43fb-ad00-a788ebb29839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_34d1325e-1e7a-4ce6-a48e-1d98052d12b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_727c593d-91d5-43fb-ad00-a788ebb29839" xlink:to="loc_us-gaap_AwardTypeAxis_34d1325e-1e7a-4ce6-a48e-1d98052d12b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa15240e-0d2e-4edf-bcfa-4af7d64e9dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_34d1325e-1e7a-4ce6-a48e-1d98052d12b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa15240e-0d2e-4edf-bcfa-4af7d64e9dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_cd4746b7-4a48-4385-bc0c-c0f662a8a6b9" xlink:href="abus-20220930.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa15240e-0d2e-4edf-bcfa-4af7d64e9dce" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_cd4746b7-4a48-4385-bc0c-c0f662a8a6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7999d125-2ec0-4a7e-a33d-b1c9f6ec9ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_727c593d-91d5-43fb-ad00-a788ebb29839" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7999d125-2ec0-4a7e-a33d-b1c9f6ec9ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_5e6ab4b4-95d3-487f-a312-4e0db3588169" xlink:href="abus-20220930.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7999d125-2ec0-4a7e-a33d-b1c9f6ec9ee1" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_5e6ab4b4-95d3-487f-a312-4e0db3588169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_29803a3c-3006-44e8-ac59-0064f4300587" xlink:href="abus-20220930.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_5e6ab4b4-95d3-487f-a312-4e0db3588169" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_29803a3c-3006-44e8-ac59-0064f4300587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue_47f987b4-764c-4587-a852-5d2853ee1096" xlink:href="abus-20220930.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_5e6ab4b4-95d3-487f-a312-4e0db3588169" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue_47f987b4-764c-4587-a852-5d2853ee1096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_0b14d7ac-bec5-4686-a174-139ac3f293a2" xlink:href="abus-20220930.xsd#abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_5e6ab4b4-95d3-487f-a312-4e0db3588169" xlink:to="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_0b14d7ac-bec5-4686-a174-139ac3f293a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_8d86b70e-4795-43aa-8014-b7d7fa43e819" xlink:href="abus-20220930.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_5e6ab4b4-95d3-487f-a312-4e0db3588169" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_8d86b70e-4795-43aa-8014-b7d7fa43e819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#FairvaluemeasurementsChangesinFairValueofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1e1b797b-b907-456e-9769-9e984fd090e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_fabfe15d-67bd-4595-8e48-4775a6b8953d" xlink:href="abus-20220930.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e1b797b-b907-456e-9769-9e984fd090e5" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_fabfe15d-67bd-4595-8e48-4775a6b8953d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ccd3be35-28a5-435a-9a33-0547465d97da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_fabfe15d-67bd-4595-8e48-4775a6b8953d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_ccd3be35-28a5-435a-9a33-0547465d97da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_af060922-a317-4a41-9985-d06e9e4b6f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_fabfe15d-67bd-4595-8e48-4775a6b8953d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_af060922-a317-4a41-9985-d06e9e4b6f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9eedea18-4dba-4ce7-8932-307043f966c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_fabfe15d-67bd-4595-8e48-4775a6b8953d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_9eedea18-4dba-4ce7-8932-307043f966c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesMarketableSecuritiesDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#InvestmentsinmarketablesecuritiesMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_089bfd14-22a6-40b2-b597-92b78642693b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_5d23e51f-82da-451c-a069-ba6c24388522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_089bfd14-22a6-40b2-b597-92b78642693b" xlink:to="loc_us-gaap_MarketableSecuritiesTable_5d23e51f-82da-451c-a069-ba6c24388522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_65ada692-3e11-4ab9-a474-f4f294b8a577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_5d23e51f-82da-451c-a069-ba6c24388522" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_65ada692-3e11-4ab9-a474-f4f294b8a577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_29f28875-e2ab-4e18-9401-577b142f7367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_65ada692-3e11-4ab9-a474-f4f294b8a577" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_29f28875-e2ab-4e18-9401-577b142f7367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_dda4afaf-2367-4302-92ee-3c312434b237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_29f28875-e2ab-4e18-9401-577b142f7367" xlink:to="loc_us-gaap_CashEquivalentsMember_dda4afaf-2367-4302-92ee-3c312434b237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_8c945f22-d022-4ebc-8f77-ab310991f343" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_5d23e51f-82da-451c-a069-ba6c24388522" xlink:to="loc_us-gaap_FinancialInstrumentAxis_8c945f22-d022-4ebc-8f77-ab310991f343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_8c945f22-d022-4ebc-8f77-ab310991f343" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentMoneyMarkeTFundMember_85233931-3bc3-4bd6-b5c9-ad980eca9842" xlink:href="abus-20220930.xsd#abus_USGovernmentMoneyMarkeTFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:to="loc_abus_USGovernmentMoneyMarkeTFundMember_85233931-3bc3-4bd6-b5c9-ad980eca9842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_27f998d3-9654-486e-a440-26c17b61fc95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_27f998d3-9654-486e-a440-26c17b61fc95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentAgencyBondsMember_0c537b56-d6b9-4158-8916-d7fb183fa1cc" xlink:href="abus-20220930.xsd#abus_USGovernmentAgencyBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:to="loc_abus_USGovernmentAgencyBondsMember_0c537b56-d6b9-4158-8916-d7fb183fa1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USCorporateBondsMember_2bce4d1b-1ea3-4242-83da-df1baf69cead" xlink:href="abus-20220930.xsd#abus_USCorporateBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:to="loc_abus_USCorporateBondsMember_2bce4d1b-1ea3-4242-83da-df1baf69cead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentBondsMember_3b36674d-79a4-492c-ae6f-dab627e647e4" xlink:href="abus-20220930.xsd#abus_USGovernmentBondsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:to="loc_abus_USGovernmentBondsMember_3b36674d-79a4-492c-ae6f-dab627e647e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_39fe0720-eb5c-40f9-951c-8b465eebc113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0e280de2-6890-4e3e-972e-ef75a840f7cc" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_39fe0720-eb5c-40f9-951c-8b465eebc113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_9ea79bc6-fc9d-49a2-8944-2c2a65282a73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_5d23e51f-82da-451c-a069-ba6c24388522" xlink:to="loc_us-gaap_InvestmentTypeAxis_9ea79bc6-fc9d-49a2-8944-2c2a65282a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_37be4939-56f6-4693-bb4c-6e1afdb5ca9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_9ea79bc6-fc9d-49a2-8944-2c2a65282a73" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_37be4939-56f6-4693-bb4c-6e1afdb5ca9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_bc495be3-ee02-4bdd-b08b-f1d30c64a8bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37be4939-56f6-4693-bb4c-6e1afdb5ca9a" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_bc495be3-ee02-4bdd-b08b-f1d30c64a8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LongTermInvestmentsMember_fbe307f3-4f92-4018-9d2d-6a531247331d" xlink:href="abus-20220930.xsd#abus_LongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_37be4939-56f6-4693-bb4c-6e1afdb5ca9a" xlink:to="loc_abus_LongTermInvestmentsMember_fbe307f3-4f92-4018-9d2d-6a531247331d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_5d23e51f-82da-451c-a069-ba6c24388522" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3d9e093-0eeb-44da-8065-833ed7972c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c3d9e093-0eeb-44da-8065-833ed7972c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_825db211-bd04-4888-a074-85590b2bb847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_825db211-bd04-4888-a074-85590b2bb847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_a3c79785-192b-42b3-ad5c-b95dda4ccc7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostCurrent_a3c79785-192b-42b3-ad5c-b95dda4ccc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_432a4e99-c882-4260-bb61-16018c6880d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_432a4e99-c882-4260-bb61-16018c6880d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4df016a0-036f-4ded-a4bd-fd3ae2f59e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4df016a0-036f-4ded-a4bd-fd3ae2f59e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d2e974db-1ee4-4e5f-b559-ec8b032bcfb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d2e974db-1ee4-4e5f-b559-ec8b032bcfb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b98b60f-7b46-44f9-a2ea-f1c52a2ba897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b98b60f-7b46-44f9-a2ea-f1c52a2ba897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0cb57a78-a931-4e83-b083-9e8fd7d1501b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0cb57a78-a931-4e83-b083-9e8fd7d1501b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_dc3ba390-3caa-4fe7-86eb-3258c701c385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent_dc3ba390-3caa-4fe7-86eb-3258c701c385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesNoncurrent_4ed71a45-1f63-431e-99c9-8c4d574e6ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_DebtSecuritiesNoncurrent_4ed71a45-1f63-431e-99c9-8c4d574e6ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_c5a88db1-18f1-48c7-a9a9-adfe627dd3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c649b040-db81-4d25-8f6e-4d269767757a" xlink:to="loc_us-gaap_LongTermInvestments_c5a88db1-18f1-48c7-a9a9-adfe627dd3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesNarrativeDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#InvestmentsinmarketablesecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c556365-92b3-4691-92c2-f82a860690f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_31fadf6c-35fd-4ec5-b73c-f07bb4a01a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c556365-92b3-4691-92c2-f82a860690f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_31fadf6c-35fd-4ec5-b73c-f07bb4a01a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3608c61e-5e2a-4ffa-adff-9269b8cba320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c556365-92b3-4691-92c2-f82a860690f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_3608c61e-5e2a-4ffa-adff-9269b8cba320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesRealizedGainLoss_7eeb1959-0113-4a47-85b3-fc37a1e86a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_6c556365-92b3-4691-92c2-f82a860690f3" xlink:to="loc_us-gaap_DebtSecuritiesRealizedGainLoss_7eeb1959-0113-4a47-85b3-fc37a1e86a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentinGenevantDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#InvestmentinGenevantDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentinGenevantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_37b908cc-c6e1-44fc-8716-656c75d28d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_da6f2a5c-a42a-48b0-86e5-e6a0516a169c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_37b908cc-c6e1-44fc-8716-656c75d28d50" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_da6f2a5c-a42a-48b0-86e5-e6a0516a169c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9960784f-7292-4043-8d7f-7feb6446c3ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_da6f2a5c-a42a-48b0-86e5-e6a0516a169c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9960784f-7292-4043-8d7f-7feb6446c3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b5d2ee76-6623-4c73-9439-fcf1567852bd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9960784f-7292-4043-8d7f-7feb6446c3ff" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b5d2ee76-6623-4c73-9439-fcf1567852bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_0dfcd295-febc-4bdd-9b50-093315e31449" xlink:href="abus-20220930.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b5d2ee76-6623-4c73-9439-fcf1567852bd" xlink:to="loc_abus_GenevantSciencesCorporationMember_0dfcd295-febc-4bdd-9b50-093315e31449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cabba9b2-54fb-4f1e-9120-a4cd2d7eebdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_da6f2a5c-a42a-48b0-86e5-e6a0516a169c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cabba9b2-54fb-4f1e-9120-a4cd2d7eebdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SubLicensingRevenuePercentage_5007cf4a-ddbe-418e-963d-17e7532ab8ad" xlink:href="abus-20220930.xsd#abus_SubLicensingRevenuePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cabba9b2-54fb-4f1e-9120-a4cd2d7eebdf" xlink:to="loc_abus_SubLicensingRevenuePercentage_5007cf4a-ddbe-418e-963d-17e7532ab8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0dbdd6b0-7628-4f9e-ae78-ce3bddc0342b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cabba9b2-54fb-4f1e-9120-a4cd2d7eebdf" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_0dbdd6b0-7628-4f9e-ae78-ce3bddc0342b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_962a0eb6-6ba6-4822-b37e-fbfe63324486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cabba9b2-54fb-4f1e-9120-a4cd2d7eebdf" xlink:to="loc_us-gaap_EquityMethodInvestments_962a0eb6-6ba6-4822-b37e-fbfe63324486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_BonaFideCollaborationPercentage_aea12887-1d44-4d93-a67c-07824688dcf6" xlink:href="abus-20220930.xsd#abus_BonaFideCollaborationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_cabba9b2-54fb-4f1e-9120-a4cd2d7eebdf" xlink:to="loc_abus_BonaFideCollaborationPercentage_aea12887-1d44-4d93-a67c-07824688dcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#AccountspayableandaccruedliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_0a20bb28-b9d2-428e-9b67-12d8b4671ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_0a20bb28-b9d2-428e-9b67-12d8b4671ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AccruedResearchAndDevelopment_a468e040-a101-4bfd-bc3c-320d292cf38e" xlink:href="abus-20220930.xsd#abus_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:to="loc_abus_AccruedResearchAndDevelopment_a468e040-a101-4bfd-bc3c-320d292cf38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_5141c6d8-bcc8-4c0e-81a4-90592f1e40c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_5141c6d8-bcc8-4c0e-81a4-90592f1e40c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AccruedPayrollCurrent_cfbcedf0-1fe9-436c-a9c5-ae45b9281d47" xlink:href="abus-20220930.xsd#abus_AccruedPayrollCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:to="loc_abus_AccruedPayrollCurrent_cfbcedf0-1fe9-436c-a9c5-ae45b9281d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7512f018-212a-483c-abc8-9aacbb13847f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_7512f018-212a-483c-abc8-9aacbb13847f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_bb51bb19-50fe-4f32-8e53-0caee490b8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6a217e4e-2b2d-4d4f-9120-b0ed53878257" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_bb51bb19-50fe-4f32-8e53-0caee490b8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SaleoffutureroyaltiesNarrativeDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#SaleoffutureroyaltiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SaleoffutureroyaltiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_37098d83-77b2-402a-b8f4-61d3ae535159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_38cfa42a-f4fc-4e16-9e1a-bba5134a25be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_37098d83-77b2-402a-b8f4-61d3ae535159" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_38cfa42a-f4fc-4e16-9e1a-bba5134a25be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c2e1972b-83d0-46b9-b8d7-068b0a4b88d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_38cfa42a-f4fc-4e16-9e1a-bba5134a25be" xlink:to="loc_srt_CounterpartyNameAxis_c2e1972b-83d0-46b9-b8d7-068b0a4b88d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f5c67af-2ec6-4c0d-beaa-bae91f99cec2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c2e1972b-83d0-46b9-b8d7-068b0a4b88d3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f5c67af-2ec6-4c0d-beaa-bae91f99cec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_289c1d48-3d74-45c9-869d-336d61fd3ada" xlink:href="abus-20220930.xsd#abus_OMERSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4f5c67af-2ec6-4c0d-beaa-bae91f99cec2" xlink:to="loc_abus_OMERSMember_289c1d48-3d74-45c9-869d-336d61fd3ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2beb1f8d-2e3d-4f73-8971-3347e7147853" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_38cfa42a-f4fc-4e16-9e1a-bba5134a25be" xlink:to="loc_srt_RangeAxis_2beb1f8d-2e3d-4f73-8971-3347e7147853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f81ff848-b288-46d0-bf59-84a2047bd557" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2beb1f8d-2e3d-4f73-8971-3347e7147853" xlink:to="loc_srt_RangeMember_f81ff848-b288-46d0-bf59-84a2047bd557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea33675b-9215-48d7-a67e-356bca51bcdc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f81ff848-b288-46d0-bf59-84a2047bd557" xlink:to="loc_srt_MinimumMember_ea33675b-9215-48d7-a67e-356bca51bcdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_14e85405-6741-404d-899d-6d14db53a446" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f81ff848-b288-46d0-bf59-84a2047bd557" xlink:to="loc_srt_MaximumMember_14e85405-6741-404d-899d-6d14db53a446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:href="abus-20220930.xsd#abus_OtherLiabilitiesDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_38cfa42a-f4fc-4e16-9e1a-bba5134a25be" xlink:to="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestPercentInterest_59d9e1c4-0723-430c-bf54-99ac08d322ee" xlink:href="abus-20220930.xsd#abus_RoyaltyInterestPercentInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_RoyaltyInterestPercentInterest_59d9e1c4-0723-430c-bf54-99ac08d322ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AnnualRevenueThreshold_1f72d0cb-6569-4a87-bc0e-f5bf301ef19d" xlink:href="abus-20220930.xsd#abus_AnnualRevenueThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_AnnualRevenueThreshold_1f72d0cb-6569-4a87-bc0e-f5bf301ef19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GrossProceedsFromRoyaltyInterestSold_78530c53-c7ac-4eb0-b009-7bbbb81bfe07" xlink:href="abus-20220930.xsd#abus_GrossProceedsFromRoyaltyInterestSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_GrossProceedsFromRoyaltyInterestSold_78530c53-c7ac-4eb0-b009-7bbbb81bfe07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_c451e9b2-ec13-4d09-af82-994766c56c18" xlink:href="abus-20220930.xsd#abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_c451e9b2-ec13-4d09-af82-994766c56c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_ea9c68a3-66e3-4a6f-acc7-90721439c0af" xlink:href="abus-20220930.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_ea9c68a3-66e3-4a6f-acc7-90721439c0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPayable_5831671e-6852-4bef-86e4-aefc77b821b0" xlink:href="abus-20220930.xsd#abus_RoyaltyPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_RoyaltyPayable_5831671e-6852-4bef-86e4-aefc77b821b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_6d602e94-61a0-4995-8c20-1f1bcd67a5e0" xlink:href="abus-20220930.xsd#abus_TransactionCostsRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_6d602e94-61a0-4995-8c20-1f1bcd67a5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EffectiveAnnualInterestRateOfRoyaltyLiability_4677a188-1a5b-4348-9f75-259e094d3088" xlink:href="abus-20220930.xsd#abus_EffectiveAnnualInterestRateOfRoyaltyLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_EffectiveAnnualInterestRateOfRoyaltyLiability_4677a188-1a5b-4348-9f75-259e094d3088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_13bc22aa-13be-4593-bdc2-df87f2167ad4" xlink:href="abus-20220930.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_13bc22aa-13be-4593-bdc2-df87f2167ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_a98aefcb-90a4-4562-b98a-17a2a448673c" xlink:href="abus-20220930.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_854854a5-a120-4b5d-91b8-455479889d88" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_a98aefcb-90a4-4562-b98a-17a2a448673c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SaleoffutureroyaltiesLiabilityActivityDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#SaleoffutureroyaltiesLiabilityActivityDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SaleoffutureroyaltiesLiabilityActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5c0997ce-4f10-4ed4-bdf2-8dfab6a02956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_ad767ef5-8302-4954-ae5d-d48a460a81e1" xlink:href="abus-20220930.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5c0997ce-4f10-4ed4-bdf2-8dfab6a02956" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_ad767ef5-8302-4954-ae5d-d48a460a81e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_26b50de7-766e-4924-bc03-c81f99e7dc19" xlink:href="abus-20220930.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_ad767ef5-8302-4954-ae5d-d48a460a81e1" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_26b50de7-766e-4924-bc03-c81f99e7dc19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome_80517b6b-afa6-4aea-bac9-e291c360837c" xlink:href="abus-20220930.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_ad767ef5-8302-4954-ae5d-d48a460a81e1" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome_80517b6b-afa6-4aea-bac9-e291c360837c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_47c64e51-ee24-425b-8ba9-66530f6996ff" xlink:href="abus-20220930.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_ad767ef5-8302-4954-ae5d-d48a460a81e1" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_47c64e51-ee24-425b-8ba9-66530f6996ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_31017a96-60a4-428f-984e-d243116f41bf" xlink:href="abus-20220930.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_ad767ef5-8302-4954-ae5d-d48a460a81e1" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_31017a96-60a4-428f-984e-d243116f41bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_762e96c1-3eaa-4259-b224-c74226a902b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5c0997ce-4f10-4ed4-bdf2-8dfab6a02956" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_762e96c1-3eaa-4259-b224-c74226a902b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e3bb4891-00f3-4412-b900-660713ad44a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_762e96c1-3eaa-4259-b224-c74226a902b0" xlink:to="loc_srt_CounterpartyNameAxis_e3bb4891-00f3-4412-b900-660713ad44a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_953b7e37-a53a-447e-8752-fa361c259640" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e3bb4891-00f3-4412-b900-660713ad44a0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_953b7e37-a53a-447e-8752-fa361c259640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ONPATTROGlobalNetSalesMember_fc96cae4-c1aa-4c0e-86c7-d2ef482dd0bd" xlink:href="abus-20220930.xsd#abus_ONPATTROGlobalNetSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_953b7e37-a53a-447e-8752-fa361c259640" xlink:to="loc_abus_ONPATTROGlobalNetSalesMember_fc96cae4-c1aa-4c0e-86c7-d2ef482dd0bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a61f7c23-0825-4a52-a4f9-b14dab534258" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_762e96c1-3eaa-4259-b224-c74226a902b0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a61f7c23-0825-4a52-a4f9-b14dab534258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5e19ef9b-ab54-4b97-a543-76b49ef8fa55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a61f7c23-0825-4a52-a4f9-b14dab534258" xlink:to="loc_us-gaap_Revenues_5e19ef9b-ab54-4b97-a543-76b49ef8fa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestPercentInterest_27ee7bf7-c4e0-4046-bdaa-c1f03b494eb4" xlink:href="abus-20220930.xsd#abus_RoyaltyInterestPercentInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a61f7c23-0825-4a52-a4f9-b14dab534258" xlink:to="loc_abus_RoyaltyInterestPercentInterest_27ee7bf7-c4e0-4046-bdaa-c1f03b494eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AnnualRevenueThreshold_60aab3c9-9a9f-49c7-bf82-7f20d36fc25d" xlink:href="abus-20220930.xsd#abus_AnnualRevenueThreshold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a61f7c23-0825-4a52-a4f9-b14dab534258" xlink:to="loc_abus_AnnualRevenueThreshold_60aab3c9-9a9f-49c7-bf82-7f20d36fc25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ContingenciesandcommitmentsDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#ContingenciesandcommitmentsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ContingenciesandcommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c501aef0-910b-4592-93ab-8be58bebb2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:href="abus-20220930.xsd#abus_ContingenciesandCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c501aef0-910b-4592-93ab-8be58bebb2b9" xlink:to="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e3874060-05be-485c-8afb-f90076600a58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:to="loc_srt_LitigationCaseAxis_e3874060-05be-485c-8afb-f90076600a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c86f7f8e-25da-49ae-b225-fbf8e52192ba" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e3874060-05be-485c-8afb-f90076600a58" xlink:to="loc_srt_LitigationCaseTypeDomain_c86f7f8e-25da-49ae-b225-fbf8e52192ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_9abff0a2-a8c9-4ee1-8822-2a821ef93f5d" xlink:href="abus-20220930.xsd#abus_ArbitrationWithTheUniversityOfBritishColumbiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_c86f7f8e-25da-49ae-b225-fbf8e52192ba" xlink:to="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_9abff0a2-a8c9-4ee1-8822-2a821ef93f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f43fd7f7-11d8-45c4-b55d-41053a6036fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:to="loc_srt_CounterpartyNameAxis_f43fd7f7-11d8-45c4-b55d-41053a6036fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2dc667c8-4646-4fcf-b51f-6b99d5e8933d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f43fd7f7-11d8-45c4-b55d-41053a6036fe" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2dc667c8-4646-4fcf-b51f-6b99d5e8933d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EnantigensSellingShareholdersMember_59070c2b-1d82-4900-bc81-004acbeaea6f" xlink:href="abus-20220930.xsd#abus_EnantigensSellingShareholdersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2dc667c8-4646-4fcf-b51f-6b99d5e8933d" xlink:to="loc_abus_EnantigensSellingShareholdersMember_59070c2b-1d82-4900-bc81-004acbeaea6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_5dfdc24f-cc55-43d2-ae8d-85835460625c" xlink:href="abus-20220930.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2dc667c8-4646-4fcf-b51f-6b99d5e8933d" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_5dfdc24f-cc55-43d2-ae8d-85835460625c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d05e36ef-0103-4d56-a818-aa4920f99c12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:to="loc_dei_LegalEntityAxis_d05e36ef-0103-4d56-a818-aa4920f99c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2986c670-94b7-4e17-a531-726708f0be72" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d05e36ef-0103-4d56-a818-aa4920f99c12" xlink:to="loc_dei_EntityDomain_2986c670-94b7-4e17-a531-726708f0be72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusInc.Member_6fdfbeee-fec1-4880-b54b-25d1cd5e3656" xlink:href="abus-20220930.xsd#abus_ArbutusInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2986c670-94b7-4e17-a531-726708f0be72" xlink:to="loc_abus_ArbutusInc.Member_6fdfbeee-fec1-4880-b54b-25d1cd5e3656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7fbb0053-dd29-449d-9c1d-41e7ed0e7836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7fbb0053-dd29-449d-9c1d-41e7ed0e7836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_432f200d-06c8-4126-b228-5ded3d87c0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7fbb0053-dd29-449d-9c1d-41e7ed0e7836" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_432f200d-06c8-4126-b228-5ded3d87c0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EnantigensSellingShareholdersMember_087e7296-8a73-4a94-9456-a157cc0cbd0b" xlink:href="abus-20220930.xsd#abus_EnantigensSellingShareholdersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_432f200d-06c8-4126-b228-5ded3d87c0b0" xlink:to="loc_abus_EnantigensSellingShareholdersMember_087e7296-8a73-4a94-9456-a157cc0cbd0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7a2c0e01-0c20-48dd-b0cc-25e4294e167a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7a2c0e01-0c20-48dd-b0cc-25e4294e167a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_cfa0b5da-16f8-4273-b8f4-951f7b132843" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7a2c0e01-0c20-48dd-b0cc-25e4294e167a" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_cfa0b5da-16f8-4273-b8f4-951f7b132843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5f33b965-11e9-4349-9e57-10957987e95d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_cfa0b5da-16f8-4273-b8f4-951f7b132843" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5f33b965-11e9-4349-9e57-10957987e95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:href="abus-20220930.xsd#abus_ContingenciesandCommitmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_e5880c13-2e74-4adb-a13c-a093518c4be5" xlink:to="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_60be47df-798a-4b20-8ceb-479512464457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_60be47df-798a-4b20-8ceb-479512464457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_e6c0670e-f150-448e-b46f-93759cd99d2f" xlink:href="abus-20220930.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_e6c0670e-f150-448e-b46f-93759cd99d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty_6cadecf2-8fe7-4e5e-bef0-a94b17a71d50" xlink:href="abus-20220930.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty_6cadecf2-8fe7-4e5e-bef0-a94b17a71d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3ee781e8-9333-40c3-9d23-ec9005dde8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_3ee781e8-9333-40c3-9d23-ec9005dde8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_2d5ad440-a4eb-47f4-902e-baf6a7887505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_2842e759-d450-4ce1-a8e4-7217a21c2fc9" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_2d5ad440-a4eb-47f4-902e-baf6a7887505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#CollaborationscontractsandlicensingagreementsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4a3cb741-23ab-4cfc-8816-e125f3a6521e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4a3cb741-23ab-4cfc-8816-e125f3a6521e" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3383b1da-fcd5-455a-a118-f566197e769a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_srt_CounterpartyNameAxis_3383b1da-fcd5-455a-a118-f566197e769a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_3383b1da-fcd5-455a-a118-f566197e769a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AssemblyBiosciencesIncMember_abfce4c5-ceac-40d5-9ffa-0ba66eb88af4" xlink:href="abus-20220930.xsd#abus_AssemblyBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_AssemblyBiosciencesIncMember_abfce4c5-ceac-40d5-9ffa-0ba66eb88af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_VaccitechMember_4dec5760-2371-4c79-98e2-76b1ca1c48e4" xlink:href="abus-20220930.xsd#abus_VaccitechMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_VaccitechMember_4dec5760-2371-4c79-98e2-76b1ca1c48e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_df72e9a1-4c58-468b-8f97-43720443badc" xlink:href="abus-20220930.xsd#abus_OMERSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_OMERSMember_df72e9a1-4c58-468b-8f97-43720443badc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AcuitasTherapeuticsInc.Member_311d6cac-9c8e-4c01-a400-8e5b5e244c38" xlink:href="abus-20220930.xsd#abus_AcuitasTherapeuticsInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_AcuitasTherapeuticsInc.Member_311d6cac-9c8e-4c01-a400-8e5b5e244c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OtherMilestoneandRoyaltyPaymentsMember_8883cfd9-3085-4d80-8002-67de978b0e48" xlink:href="abus-20220930.xsd#abus_OtherMilestoneandRoyaltyPaymentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_OtherMilestoneandRoyaltyPaymentsMember_8883cfd9-3085-4d80-8002-67de978b0e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AlnylamPharmaceuticalsIncMember_b56fca30-a795-490f-817d-8712beec284f" xlink:href="abus-20220930.xsd#abus_AlnylamPharmaceuticalsIncMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_AlnylamPharmaceuticalsIncMember_b56fca30-a795-490f-817d-8712beec284f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_243dcd78-e5fa-4dec-a74a-dfbe833907bf" xlink:href="abus-20220930.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_243dcd78-e5fa-4dec-a74a-dfbe833907bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_XChemIncAndProterosMember_d23bc23a-3ec0-4b68-919b-a259ae5e2a55" xlink:href="abus-20220930.xsd#abus_XChemIncAndProterosMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_XChemIncAndProterosMember_d23bc23a-3ec0-4b68-919b-a259ae5e2a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ONPATTROGlobalNetSalesMember_197f6d90-e84b-4415-87ff-cb1a5377f84b" xlink:href="abus-20220930.xsd#abus_ONPATTROGlobalNetSalesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ffb0bf4f-632a-49d8-94e5-f2eef3429d2b" xlink:to="loc_abus_ONPATTROGlobalNetSalesMember_197f6d90-e84b-4415-87ff-cb1a5377f84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c47d312e-c99a-46c2-8fc8-1618ac963e9f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_srt_RangeAxis_c47d312e-c99a-46c2-8fc8-1618ac963e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f508e2a2-09a3-42ed-8f85-f9c217b21c4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c47d312e-c99a-46c2-8fc8-1618ac963e9f" xlink:to="loc_srt_RangeMember_f508e2a2-09a3-42ed-8f85-f9c217b21c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dff860d9-dbaa-4331-ab5f-3c5773277507" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f508e2a2-09a3-42ed-8f85-f9c217b21c4e" xlink:to="loc_srt_MinimumMember_dff860d9-dbaa-4331-ab5f-3c5773277507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_042b4619-ae31-4edb-a3af-e82df30788ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f508e2a2-09a3-42ed-8f85-f9c217b21c4e" xlink:to="loc_srt_MaximumMember_042b4619-ae31-4edb-a3af-e82df30788ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_65be57bf-830f-484f-843f-01161752088d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_srt_ProductOrServiceAxis_65be57bf-830f-484f-843f-01161752088d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0ee8f4c7-502b-44b8-a4ee-fcae6e5366d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_65be57bf-830f-484f-843f-01161752088d" xlink:to="loc_srt_ProductsAndServicesDomain_0ee8f4c7-502b-44b8-a4ee-fcae6e5366d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_ea25a522-e5d9-445f-8442-2c03b20f59df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ee8f4c7-502b-44b8-a4ee-fcae6e5366d8" xlink:to="loc_us-gaap_LicenseMember_ea25a522-e5d9-445f-8442-2c03b20f59df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_45c555e4-fb25-48da-97d6-384f946bebd7" xlink:href="abus-20220930.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0ee8f4c7-502b-44b8-a4ee-fcae6e5366d8" xlink:to="loc_abus_NonCashRoyaltyMember_45c555e4-fb25-48da-97d6-384f946bebd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_89277f0d-d303-4417-bede-7ba859e2fcae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_89277f0d-d303-4417-bede-7ba859e2fcae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ec1a5ba4-c905-4886-b381-8cbe674e0da7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_89277f0d-d303-4417-bede-7ba859e2fcae" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ec1a5ba4-c905-4886-b381-8cbe674e0da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7f66f914-a4ea-469c-864b-6e5435f4cf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7f66f914-a4ea-469c-864b-6e5435f4cf4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_615a5045-b539-44b6-a720-9199eedf684a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_7f66f914-a4ea-469c-864b-6e5435f4cf4a" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_615a5045-b539-44b6-a720-9199eedf684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4e81feed-7a52-471b-b04b-aefc91d6d218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4e81feed-7a52-471b-b04b-aefc91d6d218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0b5448bf-9957-464c-9e3f-fe72d7c1f7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4e81feed-7a52-471b-b04b-aefc91d6d218" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0b5448bf-9957-464c-9e3f-fe72d7c1f7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OneTimeUpfrontCashPaymentMember_1aee62a1-8a91-4ae9-bdb8-2b0c2cceca43" xlink:href="abus-20220930.xsd#abus_OneTimeUpfrontCashPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0b5448bf-9957-464c-9e3f-fe72d7c1f7ee" xlink:to="loc_abus_OneTimeUpfrontCashPaymentMember_1aee62a1-8a91-4ae9-bdb8-2b0c2cceca43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2d23e19f-f409-4ccb-b66d-fa37f7c68913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2d23e19f-f409-4ccb-b66d-fa37f7c68913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b813d409-7df3-4454-8e46-91b6b41f2338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2d23e19f-f409-4ccb-b66d-fa37f7c68913" xlink:to="loc_us-gaap_ClassOfStockDomain_b813d409-7df3-4454-8e46-91b6b41f2338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8394f4d3-4d90-4814-be45-1a885d0eef53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b813d409-7df3-4454-8e46-91b6b41f2338" xlink:to="loc_us-gaap_CommonStockMember_8394f4d3-4d90-4814-be45-1a885d0eef53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a1fab710-0c13-485f-ab78-5ab32f4cb2ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_srt_OwnershipAxis_a1fab710-0c13-485f-ab78-5ab32f4cb2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a28d05be-a870-4366-8b2c-20a8874030e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_a1fab710-0c13-485f-ab78-5ab32f4cb2ae" xlink:to="loc_srt_OwnershipDomain_a28d05be-a870-4366-8b2c-20a8874030e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_0a8d1bc7-d97d-4a41-9a89-48d2257b9a16" xlink:href="abus-20220930.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_a28d05be-a870-4366-8b2c-20a8874030e6" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_0a8d1bc7-d97d-4a41-9a89-48d2257b9a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e145b882-d07e-4165-8eef-80da63078783" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_srt_MajorCustomersAxis_e145b882-d07e-4165-8eef-80da63078783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b7dd4b5e-47f8-4259-a78d-b39230ccde45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_e145b882-d07e-4165-8eef-80da63078783" xlink:to="loc_srt_NameOfMajorCustomerDomain_b7dd4b5e-47f8-4259-a78d-b39230ccde45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_55f8fdc2-dd34-4a8d-8c2a-b2bf350a65cd" xlink:href="abus-20220930.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b7dd4b5e-47f8-4259-a78d-b39230ccde45" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_55f8fdc2-dd34-4a8d-8c2a-b2bf350a65cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_0502def4-fc9d-4599-af09-e3fa24f914ff" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyEntitlements_f7e4cc13-ed04-4b8f-aacd-995802249ac0" xlink:href="abus-20220930.xsd#abus_RoyaltyEntitlements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_RoyaltyEntitlements_f7e4cc13-ed04-4b8f-aacd-995802249ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AnnualRevenueThreshold_a5d57591-6562-4636-8e89-730311b1cf99" xlink:href="abus-20220930.xsd#abus_AnnualRevenueThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_AnnualRevenueThreshold_a5d57591-6562-4636-8e89-730311b1cf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d1595bcf-45dd-4c64-bacd-1e9835a4814a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_Revenues_d1595bcf-45dd-4c64-bacd-1e9835a4814a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GrossProceedsFromRoyaltyInterestSold_f192d3c2-d412-4f2d-9a27-6b3d7a87e166" xlink:href="abus-20220930.xsd#abus_GrossProceedsFromRoyaltyInterestSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_GrossProceedsFromRoyaltyInterestSold_f192d3c2-d412-4f2d-9a27-6b3d7a87e166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_58b1120e-935c-4680-84e1-3759f21abbdb" xlink:href="abus-20220930.xsd#abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_58b1120e-935c-4680-84e1-3759f21abbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_02d6963b-5aee-4049-9c46-620ae05cf762" xlink:href="abus-20220930.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_02d6963b-5aee-4049-9c46-620ae05cf762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPayable_d3b80fec-f2d5-4064-94c5-d157d74909da" xlink:href="abus-20220930.xsd#abus_RoyaltyPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_RoyaltyPayable_d3b80fec-f2d5-4064-94c5-d157d74909da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7da33300-26d7-4ea6-b72d-dc625667c1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PotentialMilestonePayments_780ffcf5-6235-44a3-bb8b-bce62ff4bb61" xlink:href="abus-20220930.xsd#abus_PotentialMilestonePayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_PotentialMilestonePayments_780ffcf5-6235-44a3-bb8b-bce62ff4bb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_193ff3a8-cc06-4ffc-8d60-7e8e9cbfc0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_ProceedsFromCollaborators_193ff3a8-cc06-4ffc-8d60-7e8e9cbfc0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6f8f3f6a-a6b4-4298-88aa-493f6fecbf28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_CommonStockSharesIssued_6f8f3f6a-a6b4-4298-88aa-493f6fecbf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_34a8f3ea-815f-4f3b-bb20-b58cfda294e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_SharePrice_34a8f3ea-815f-4f3b-bb20-b58cfda294e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dc46b83f-442f-4884-b0e5-09614748c9c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_dc46b83f-442f-4884-b0e5-09614748c9c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2a7454e-5f41-4652-bb75-67e8f516bc27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_b2a7454e-5f41-4652-bb75-67e8f516bc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_270e1a16-5ff6-4e42-aa46-bc3bce01dddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_270e1a16-5ff6-4e42-aa46-bc3bce01dddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_a433f9a6-004a-48c9-8409-3862c5f7cbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_ContractWithCustomerLiability_a433f9a6-004a-48c9-8409-3862c5f7cbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_deb02809-e3e4-4073-bb2e-7289f104adba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_DeferredRevenueCurrent_deb02809-e3e4-4073-bb2e-7289f104adba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_44b04d29-47cd-4230-be8a-ece474f26218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_44b04d29-47cd-4230-be8a-ece474f26218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_90ee238d-26e0-405b-ba51-95b2828bcaca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_IncomeTaxesPaid_90ee238d-26e0-405b-ba51-95b2828bcaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638a34a9-2a0d-4a2c-a026-fe041d823f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_638a34a9-2a0d-4a2c-a026-fe041d823f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCostsGross_8f7a4e4a-acfd-45a9-8fc4-454fa3b2cacd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDeferredCostsGross"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_OtherDeferredCostsGross_8f7a4e4a-acfd-45a9-8fc4-454fa3b2cacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PremiumonClosingStockPrice_35039e25-d356-4595-8ec5-ee6bd47c2dd2" xlink:href="abus-20220930.xsd#abus_PremiumonClosingStockPrice"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_PremiumonClosingStockPrice_35039e25-d356-4595-8ec5-ee6bd47c2dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_f87b2ca6-df28-47da-804f-14084ed35e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_f87b2ca6-df28-47da-804f-14084ed35e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_f0a71aca-94b4-4658-841c-e20de2acaf03" xlink:href="abus-20220930.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_f0a71aca-94b4-4658-841c-e20de2acaf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_5314119d-c07d-4db1-8778-59963adffd44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_PremiumsEarnedNet_5314119d-c07d-4db1-8778-59963adffd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_e1a09317-bfd0-42ed-8781-f7e4e319777f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_e1a09317-bfd0-42ed-8781-f7e4e319777f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestPercentInterest_3a19b51e-2439-420b-87d5-9af4e83a83c2" xlink:href="abus-20220930.xsd#abus_RoyaltyInterestPercentInterest"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_abus_RoyaltyInterestPercentInterest_3a19b51e-2439-420b-87d5-9af4e83a83c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_4298f3e2-9c8d-4f16-934d-20e7f597b211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_67073bce-3d23-4ef3-aecc-9fb6521696ce" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_4298f3e2-9c8d-4f16-934d-20e7f597b211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ShareholdersequityNarrativeDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#ShareholdersequityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ShareholdersequityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_ec8329cb-d0b4-452b-9e50-a1d47d85b527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_ec8329cb-d0b4-452b-9e50-a1d47d85b527" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1ea522de-1a3d-45ad-acbd-47ad47242750" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:to="loc_srt_CounterpartyNameAxis_1ea522de-1a3d-45ad-acbd-47ad47242750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a34951dd-36be-4747-aaef-8b721ab45016" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1ea522de-1a3d-45ad-acbd-47ad47242750" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a34951dd-36be-4747-aaef-8b721ab45016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_JefferiesLLCMember_bfbf3298-3429-4be5-8370-cc314b306522" xlink:href="abus-20220930.xsd#abus_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a34951dd-36be-4747-aaef-8b721ab45016" xlink:to="loc_abus_JefferiesLLCMember_bfbf3298-3429-4be5-8370-cc314b306522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoivantSciencesLtdMember_e07134a8-bc4d-4e18-ac33-17a6551f4932" xlink:href="abus-20220930.xsd#abus_RoivantSciencesLtdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a34951dd-36be-4747-aaef-8b721ab45016" xlink:to="loc_abus_RoivantSciencesLtdMember_e07134a8-bc4d-4e18-ac33-17a6551f4932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_49c8a05e-c7cd-4cda-9d24-003801943aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:to="loc_us-gaap_StatementClassOfStockAxis_49c8a05e-c7cd-4cda-9d24-003801943aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b5978041-63e4-421c-893d-ef8fc251a42c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_49c8a05e-c7cd-4cda-9d24-003801943aa6" xlink:to="loc_us-gaap_ClassOfStockDomain_b5978041-63e4-421c-893d-ef8fc251a42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_05007c1a-255b-4144-b666-736f2097e2d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b5978041-63e4-421c-893d-ef8fc251a42c" xlink:to="loc_us-gaap_CommonStockMember_05007c1a-255b-4144-b666-736f2097e2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_97ff6e1d-d9f1-4566-9851-f83c64836234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b5978041-63e4-421c-893d-ef8fc251a42c" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_97ff6e1d-d9f1-4566-9851-f83c64836234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9ca70a10-a164-4bf9-bc81-25727d594bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9ca70a10-a164-4bf9-bc81-25727d594bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9ca70a10-a164-4bf9-bc81-25727d594bf5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020RegistrationStmtMember_92f37da3-d8ab-4728-9b56-4e9c6d38b403" xlink:href="abus-20220930.xsd#abus_Jan2020RegistrationStmtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_Jan2020RegistrationStmtMember_92f37da3-d8ab-4728-9b56-4e9c6d38b403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SaleAgreementMember_6265dc85-4134-4c62-bf73-04ec78141a24" xlink:href="abus-20220930.xsd#abus_SaleAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_SaleAgreementMember_6265dc85-4134-4c62-bf73-04ec78141a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Oct2020RegistrationStmtMember_b6eeb01e-1b1b-4f33-801b-f9154473432a" xlink:href="abus-20220930.xsd#abus_Oct2020RegistrationStmtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_Oct2020RegistrationStmtMember_b6eeb01e-1b1b-4f33-801b-f9154473432a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Nov2021RegistrationStmtMember_b9e3fe9b-8dd0-4359-9acc-322fc6b98e66" xlink:href="abus-20220930.xsd#abus_Nov2021RegistrationStmtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_Nov2021RegistrationStmtMember_b9e3fe9b-8dd0-4359-9acc-322fc6b98e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Mar2021ProspectusSupplementAgreementMember_ee0ed7bf-c79e-43da-aa09-f3480a3400ca" xlink:href="abus-20220930.xsd#abus_Mar2021ProspectusSupplementAgreementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_Mar2021ProspectusSupplementAgreementMember_ee0ed7bf-c79e-43da-aa09-f3480a3400ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_October2021ProspectusSupplementMember_63c63319-d410-40e7-a141-01c36202f904" xlink:href="abus-20220930.xsd#abus_October2021ProspectusSupplementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_October2021ProspectusSupplementMember_63c63319-d410-40e7-a141-01c36202f904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_March2022ProspectusSupplementMember_72618dc4-70d5-4f72-b768-2d3151657039" xlink:href="abus-20220930.xsd#abus_March2022ProspectusSupplementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_March2022ProspectusSupplementMember_72618dc4-70d5-4f72-b768-2d3151657039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020ProspectusSupplementMember_d8c714fc-e2da-4680-ba93-07535404b991" xlink:href="abus-20220930.xsd#abus_Jan2020ProspectusSupplementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_Jan2020ProspectusSupplementMember_d8c714fc-e2da-4680-ba93-07535404b991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Aug2020ProspectusSupplementMember_652ae7c8-1019-4c11-91aa-17d74145e6e9" xlink:href="abus-20220930.xsd#abus_Aug2020ProspectusSupplementMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c1d2d452-b15e-4129-8786-02838259ab4a" xlink:to="loc_abus_Aug2020ProspectusSupplementMember_652ae7c8-1019-4c11-91aa-17d74145e6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RegistrationStatementAxis_4e51db28-f6c2-4b8a-beb0-115734e882ba" xlink:href="abus-20220930.xsd#abus_RegistrationStatementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:to="loc_abus_RegistrationStatementAxis_4e51db28-f6c2-4b8a-beb0-115734e882ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RegistrationStatementDomain_af4bb0cd-7aab-4042-9394-cd1ef1ffe164" xlink:href="abus-20220930.xsd#abus_RegistrationStatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementAxis_4e51db28-f6c2-4b8a-beb0-115734e882ba" xlink:to="loc_abus_RegistrationStatementDomain_af4bb0cd-7aab-4042-9394-cd1ef1ffe164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020RegistrationStmtMember_daaf6067-2b61-446b-b4c6-39aef40a35a7" xlink:href="abus-20220930.xsd#abus_Jan2020RegistrationStmtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementDomain_af4bb0cd-7aab-4042-9394-cd1ef1ffe164" xlink:to="loc_abus_Jan2020RegistrationStmtMember_daaf6067-2b61-446b-b4c6-39aef40a35a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Oct2020RegistrationStmtMember_c08cb262-cd81-48f7-9222-363c2cea83cb" xlink:href="abus-20220930.xsd#abus_Oct2020RegistrationStmtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementDomain_af4bb0cd-7aab-4042-9394-cd1ef1ffe164" xlink:to="loc_abus_Oct2020RegistrationStmtMember_c08cb262-cd81-48f7-9222-363c2cea83cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020Oct2020AndNov2021RegistrationStmtsMember_7657a982-3cb7-4696-9199-06cd8240e813" xlink:href="abus-20220930.xsd#abus_Jan2020Oct2020AndNov2021RegistrationStmtsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementDomain_af4bb0cd-7aab-4042-9394-cd1ef1ffe164" xlink:to="loc_abus_Jan2020Oct2020AndNov2021RegistrationStmtsMember_7657a982-3cb7-4696-9199-06cd8240e813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_37f179eb-6306-410f-828e-4a9018d9fb03" xlink:to="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_52b9129b-543f-4399-b7ed-7b4fefe02bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesSubscriptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_52b9129b-543f-4399-b7ed-7b4fefe02bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b5cd5401-c994-4ca2-9c8f-8c33e807ee52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b5cd5401-c994-4ca2-9c8f-8c33e807ee52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8433f4a0-d462-400b-908d-d13d3303afc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8433f4a0-d462-400b-908d-d13d3303afc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7d81f537-a0fa-4e60-b90c-fe7e093d1b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7d81f537-a0fa-4e60-b90c-fe7e093d1b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b9290b15-f1d0-411e-adf7-0ab57d1d37ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_b9290b15-f1d0-411e-adf7-0ab57d1d37ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PremiumonClosingStockPrice_4b36814c-5bba-4e9d-8b8b-0df58427447c" xlink:href="abus-20220930.xsd#abus_PremiumonClosingStockPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_abus_PremiumonClosingStockPrice_4b36814c-5bba-4e9d-8b8b-0df58427447c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_357e2906-8d8a-476a-8560-340c12218540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_SharePrice_357e2906-8d8a-476a-8560-340c12218540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_1fc531e6-3805-4378-be0e-425d4fb07705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_1fc531e6-3805-4378-be0e-425d4fb07705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_3ef78377-221d-47ac-8ed5-63bd5497bed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_3ef78377-221d-47ac-8ed5-63bd5497bed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion_899717d0-7d8b-47d3-98d9-0dc07f65bb67" xlink:href="abus-20220930.xsd#abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion_899717d0-7d8b-47d3-98d9-0dc07f65bb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_babfaab7-0922-4cc3-b3e6-1d74917360c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a1549166-8a73-4e6e-8fc3-2a885a2ade35" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_babfaab7-0922-4cc3-b3e6-1d74917360c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ShareholdersequityStockbasedCompensationDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#ShareholdersequityStockbasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ShareholdersequityStockbasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_30b941f1-f05e-46c5-97e6-c0a3a7c89944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_30b941f1-f05e-46c5-97e6-c0a3a7c89944" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03268682-f7b0-461b-bf62-7785b97566e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:to="loc_us-gaap_PlanNameAxis_03268682-f7b0-461b-bf62-7785b97566e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dd6745ce-56b5-4c2c-8024-3613cf0359b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_03268682-f7b0-461b-bf62-7785b97566e8" xlink:to="loc_us-gaap_PlanNameDomain_dd6745ce-56b5-4c2c-8024-3613cf0359b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_fe8e56b9-0ca0-4a7a-870a-75c18d750f7c" xlink:href="abus-20220930.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dd6745ce-56b5-4c2c-8024-3613cf0359b8" xlink:to="loc_abus_ArbutusPlansMember_fe8e56b9-0ca0-4a7a-870a-75c18d750f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ddf35aca-4387-409e-95a3-aea42c940657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ddf35aca-4387-409e-95a3-aea42c940657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4f5a140f-f938-4a18-a964-e8bc814861c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ddf35aca-4387-409e-95a3-aea42c940657" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4f5a140f-f938-4a18-a964-e8bc814861c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e3a3eca5-4831-4106-9457-9babd13d7bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f5a140f-f938-4a18-a964-e8bc814861c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e3a3eca5-4831-4106-9457-9babd13d7bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1295e64a-96d6-4309-9428-d016ad63c4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f5a140f-f938-4a18-a964-e8bc814861c8" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1295e64a-96d6-4309-9428-d016ad63c4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ab20c964-fd9f-4967-a902-59264987a9ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:to="loc_srt_CounterpartyNameAxis_ab20c964-fd9f-4967-a902-59264987a9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f45381d-e926-4ead-963e-075593140334" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ab20c964-fd9f-4967-a902-59264987a9ee" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f45381d-e926-4ead-963e-075593140334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_JefferiesLLCMember_80b61929-898b-41d9-8ad7-7bb94ffb5033" xlink:href="abus-20220930.xsd#abus_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6f45381d-e926-4ead-963e-075593140334" xlink:to="loc_abus_JefferiesLLCMember_80b61929-898b-41d9-8ad7-7bb94ffb5033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0f1bc726-4749-4b0b-9185-5daa0ea279e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0f1bc726-4749-4b0b-9185-5daa0ea279e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7bdbda59-4200-4aa8-9eaa-08782744be42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0f1bc726-4749-4b0b-9185-5daa0ea279e1" xlink:to="loc_us-gaap_ClassOfStockDomain_7bdbda59-4200-4aa8-9eaa-08782744be42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_def4e748-2469-4418-83c1-8f437e15caed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7bdbda59-4200-4aa8-9eaa-08782744be42" xlink:to="loc_us-gaap_CommonStockMember_def4e748-2469-4418-83c1-8f437e15caed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37c1f4e0-c4a4-4584-879f-433c7e57eeae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_99ccc00b-c2c8-4125-9485-99e436d00ced" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37c1f4e0-c4a4-4584-879f-433c7e57eeae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_babf093e-928c-45a5-8ed4-2b38663df59d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37c1f4e0-c4a4-4584-879f-433c7e57eeae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_babf093e-928c-45a5-8ed4-2b38663df59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3a9af5af-c565-464c-8163-38ae54006ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37c1f4e0-c4a4-4584-879f-433c7e57eeae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3a9af5af-c565-464c-8163-38ae54006ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c440aaad-a4d1-4872-9bc6-8ab6a662c761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37c1f4e0-c4a4-4584-879f-433c7e57eeae" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c440aaad-a4d1-4872-9bc6-8ab6a662c761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1c48de81-fbce-4cb6-ad20-01c24199a2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_37c1f4e0-c4a4-4584-879f-433c7e57eeae" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1c48de81-fbce-4cb6-ad20-01c24199a2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/RelatedpartytransactionsDetails" xlink:type="simple" xlink:href="abus-20220930.xsd#RelatedpartytransactionsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/RelatedpartytransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_2fd29720-5100-4c4e-bd9b-921a07501743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_571d2098-5977-492e-b363-eda2a7409d29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_2fd29720-5100-4c4e-bd9b-921a07501743" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_571d2098-5977-492e-b363-eda2a7409d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_fe5ac01f-52ac-4776-b757-9aa3dbbc069f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_571d2098-5977-492e-b363-eda2a7409d29" xlink:to="loc_srt_CounterpartyNameAxis_fe5ac01f-52ac-4776-b757-9aa3dbbc069f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e718967-91be-40d1-a35c-61148e5dec72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_fe5ac01f-52ac-4776-b757-9aa3dbbc069f" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e718967-91be-40d1-a35c-61148e5dec72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_5cc5660e-3726-424b-96e0-4282922a13a3" xlink:href="abus-20220930.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e718967-91be-40d1-a35c-61148e5dec72" xlink:to="loc_abus_GenevantSciencesCorporationMember_5cc5660e-3726-424b-96e0-4282922a13a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b091e137-18ce-48b3-aa91-1c3bf4a1b1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_571d2098-5977-492e-b363-eda2a7409d29" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b091e137-18ce-48b3-aa91-1c3bf4a1b1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_acc56230-e0b4-46f3-911f-109595bc0236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b091e137-18ce-48b3-aa91-1c3bf4a1b1c7" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_acc56230-e0b4-46f3-911f-109595bc0236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ResearchAndDevelopmentServicesMember_70a5625f-ab97-451f-84f7-62e52acf7fd3" xlink:href="abus-20220930.xsd#abus_ResearchAndDevelopmentServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_acc56230-e0b4-46f3-911f-109595bc0236" xlink:to="loc_abus_ResearchAndDevelopmentServicesMember_70a5625f-ab97-451f-84f7-62e52acf7fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d70b587d-e1b2-40d2-9e4f-0227fdd61daa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_571d2098-5977-492e-b363-eda2a7409d29" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d70b587d-e1b2-40d2-9e4f-0227fdd61daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_25ed53e2-87c3-4840-824b-8ae8cac9ca7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d70b587d-e1b2-40d2-9e4f-0227fdd61daa" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_25ed53e2-87c3-4840-824b-8ae8cac9ca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
